Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
Experimental and clinical research has supported the use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in diabetic, hypertensive and proteinuric nephropathies. This review will evaluate the role of angiotens..... Read More